Life Sciences Group Of The Year: Gibson Dunn
Gibson Dunn & Crutcher LLP's life sciences group helped Novartis beat a challenge over its multiple sclerosis drug Gilenya and advised on a number of biotech initial public offerings, landing it...To view the full article, register now.
Already a subscriber? Click here to view full article